“…Various methods have been developed in an attempt to overcome this problem. Examples include microinjection, surface binding to viral capsids, attaching lipophilic pendant groups, and lipid encapsulation, plus a variety of other methods (Bennett et al, 1992;Chin et al, 1990;Leonetti et al, 1991;Letsinger et al, 1986;McLachlin et al, 1990;Spiller et al, 1998;Takle et al, 1997). With both endogenous uptake and most augmented delivery methods, ODN localize primarily to cellular lysosomes (Bergan et al, 1993;Bergan, 1997;Loke et al, 1989).…”